The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma (aHCC): 3-year follow-up of the phase 2 KEYNOTE-224 study.
 
Ivan Borbath
Honoraria - Bayer (Inst); Roche/Genentech (Inst); Taiho Pharmaceutical (Inst)
Consulting or Advisory Role - Lilly (Inst)
Research Funding - SERVIER (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst)
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Mark Karwal
Consulting or Advisory Role - Eisai
Research Funding - Eisai (Inst); Merck (Inst)
 
Chris Verslype
Consulting or Advisory Role - Bayer; Ipsen; Novartis; Roche
Speakers' Bureau - BAYER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen
 
Hans Van Vlierberghe
Patents, Royalties, Other Intellectual Property - UGent
 
Adel Kardosh
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Eisai; Exelixis; Exelixis
Research Funding - Natera
 
Francesca Bergamo
No Relationships to Disclose
 
Per Stål
Consulting or Advisory Role - MSD
 
Debashis Sarker
Honoraria - Bayer; Ipsen
Consulting or Advisory Role - AAA HealthCare; Bayer; Eisai; Ipsen; Novartis; Roche; Sirtex Medical; Surface Oncology; UCB (Inst)
Speakers' Bureau - AstraZeneca; Bayer; Eisai
Research Funding - UCB (Inst)
Travel, Accommodations, Expenses - MiNA Therapeutics
(OPTIONAL) Uncompensated Relationships - Medivir; MINA THERAPEUTICS
 
Daniel H. Palmer
Consulting or Advisory Role - AstraZeneca; BMS (Inst); Boston Scientific; Eisai; MSD; Roche; Sirtex Medical; Viatris
Research Funding - AstraZeneca; Bayer; BMS; Nucana; Sirtex Medical
 
Julien Edeline
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Basilea; Bayer; Boston Scientific; Bristol-Myers Squibb; BTG; Eisai; Ipsen; Merck Serono; MSD; Roche; SERVIER
Research Funding - Beigene (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Stéphane Cattan
Honoraria - AstraZeneca; Bayer; Ipsen; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Roche
Expert Testimony - AstraZeneca; Ipsen; Roche
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Roche
Other Relationship - AstraZeneca; Bayer; Ipsen; Roche
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - BMS; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ann-Lii Cheng
Honoraria - AstraZeneca; Bayer Yakuhin; Eisai; Genentech/Roche
Consulting or Advisory Role - AstraZeneca; Bayer Schering Pharma; BeiGene; Bristol-Myers Squibb; Eisai; Genentech/Roche; Ipsen; IQVIA; MSD; Ono Pharmaceutical; Roche
 
Sadahisa Ogasawara
Honoraria - AstraZeneca/Daiichi Sankyo; Bayer; Chugai Pharma; Eisai; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Lilly; Merck
Research Funding - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly
 
Abby B. Siegel
Employment - Merck
 
Ken Hatogai
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Anran Wang
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Arndt Vogel
Honoraria - Advanced Accelerator Applications/Imaging Equipment Ltd; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daichi-Sankyo; Incyte; Ipsen; Janssen; Lilly; MSD; Pierre Fabre; Roche; Sanofi; Sirtex Medical; TERUMO; TERUMO
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Daichi-Sankyo; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche; Sirtex Medical; Terumo
Research Funding - Novartis
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Roche